Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ahmed Farag

Vascular & Interventional Radiology Panama City, FL Medical Doctor

NPI 1659722361 CMS profile 1569848

2401 State Ave Ste 100, Panama City, FL 32405

Open in the dashboard

General payments

$64,938

249 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ahmed Farag of Panama City, FL is reported in the CMS Open Payments database as having received $64,938 across 249 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40,841 98
2024 General $15,912 84
2023 General $1,481 18
2022 General $4,288 34
2021 General $497 2
2020 General $137 1
2019 General $1,783 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ahmed Farag
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Ahmed Farag were reported at $40,841. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Ahmed Farag Vascular & Interventional Radiology median Middle half National median
2019 $1,783 $422 $125–$1,555 $163
2020 $137 $200 $68–$652 $114
2021 $497 $280 $99–$866 $132
2022 $4,288 $433 $137–$1,497 $149
2023 $1,481 $506 $152–$2,019 $160
2024 $15,912 $556 $175–$1,930 $164
2025 $40,841 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $43,354 21 payments
  2. Asahi Intecc USA, Inc. $6,584 19 payments
  3. Penumbra, Inc. $3,722 19 payments
  4. Inari Medical, Inc. $2,354 71 payments
  5. Boston Scientific Corporation $1,426 14 payments
  6. Terumo Medical Corporation $1,182 11 payments
  7. Philips Electronics North America Corporation $952 14 payments
  8. Medtronic, Inc. $773 13 payments
  9. Cook Medical LLC $743 8 payments
  10. Abbott Laboratories $738 2 payments
  11. Other $3,112 57 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $41,500 2 payments
  2. Food and Beverage $12,383 219 payments
  3. Honoraria $5,000 1 payment
  4. Travel and Lodging $4,806 23 payments
  5. Grant $782 2 payments
  6. Consulting Fee $400 1 payment
  7. Education $68 1 payment
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac Cv $30,000 1 payment
  2. Auryon Laser System 100-120 Vac Et $11,500 1 payment
  3. Asahi Coronary Wires $5,100 3 payments
  4. Indigo System $3,585 18 payments
  5. CT THROMBECTOMY SYSTEM KIT $2,416 81 payments
  6. FLOWTRIEVER CATHETER, S $2,416 81 payments
  7. AURYON LASER SYSTEM 100-120 VAC Pad $1,489 16 payments
  8. GLIDESHEATH SLENDER $1,148 9 payments
  9. Asahi Peripheral Vascular Wires $815 7 payments
  10. Diamondback Coronary $738 2 payments
  11. Other $7,995 118 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

31

Median for Diagnostic Radiology: 24

Drug cost

$21

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Alprazolam Generic 31 $21

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$606,404

Of which drugs: $942

Medicare patients

297

Average age 73

Services billed

6,910

164 women, 133 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 66%
Ischemic heart disease 47%
Diabetes 46%
Chronic kidney disease 44%
Heart failure 37%
COPD 36%
Depression 34%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 53 6,186 $663

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

249 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record